tiprankstipranks
Advertisement
Advertisement

TOVX Stock Latest News

3 Penny Stocks to Watch Now, 4/21/26
Market News3 Penny Stocks to Watch Now, 4/21/26
11d ago
PBM
ENVB
Theriva Biologics Highlights Positive VCN-01 Pancreatic Cancer Data
PremiumCompany Announcements
Theriva Biologics Highlights Positive VCN-01 Pancreatic Cancer Data
15d ago
8K
TOVX
Theriva Biologics to present additional data on Phase 2b VCN-01Clinical Trial
PremiumThe Fly
Theriva Biologics to present additional data on Phase 2b VCN-01Clinical Trial
15d ago
TOVX
Theriva Biologics Faces Delays in Warrant Approval Meeting
PremiumCompany Announcements
Theriva Biologics Faces Delays in Warrant Approval Meeting
23d ago
8K
TOVX
Theriva Biologics upgraded to Buy at Maxim on clearer VCN-01 path
PremiumThe Fly
Theriva Biologics upgraded to Buy at Maxim on clearer VCN-01 path
1M ago
TOVX
Theriva Biologics upgraded to Buy from Hold at Maxim
PremiumThe FlyTheriva Biologics upgraded to Buy from Hold at Maxim
1M ago
TOVX
Theriva Biologics Advances VCN-01 Into Pivotal Phase 3
Premium
Company Announcements
Theriva Biologics Advances VCN-01 Into Pivotal Phase 3
1M ago
8K
TOVX
Theriva Biologics announces outcome of Type B End-of-Phase 2 meeting with FDA
Premium
The Fly
Theriva Biologics announces outcome of Type B End-of-Phase 2 meeting with FDA
1M ago
TOVX
Theriva Biologics price target lowered to $4 from $7 at Alliance Global
PremiumThe Fly
Theriva Biologics price target lowered to $4 from $7 at Alliance Global
2M ago
TOVX
Theriva Biologics reports FY25 EPS ($2.08) vs. ($19.03) last year
PremiumThe Fly
Theriva Biologics reports FY25 EPS ($2.08) vs. ($19.03) last year
2M ago
TOVX
Theriva Biologics sees cash runway into 1Q27
PremiumThe Fly
Theriva Biologics sees cash runway into 1Q27
2M ago
TOVX
Theriva Licenses SYN-020, Refocuses on Cancer Pipeline
PremiumCompany Announcements
Theriva Licenses SYN-020, Refocuses on Cancer Pipeline
2M ago
8K
TOVX
Theriva Biologics licenses SYN-020 to Rasayana Therapeutics
PremiumThe FlyTheriva Biologics licenses SYN-020 to Rasayana Therapeutics
2M ago
TOVX
Theriva Biologics Faces Delay in Warrant Approval Meeting
Premium
Company Announcements
Theriva Biologics Faces Delay in Warrant Approval Meeting
3M ago
8K
TOVX
Theriva Biologics advances VCN-01 toward Phase 3 trial
Premium
Company Announcements
Theriva Biologics advances VCN-01 toward Phase 3 trial
4M ago
8K
TOVX
Theriva Biologics Gains EMA Backing for VCN-01 Phase 3
PremiumCompany Announcements
Theriva Biologics Gains EMA Backing for VCN-01 Phase 3
4M ago
8K
TOVX
Theriva Biologics receives CHMP scientific advice on VCN-01 Phase 3 design
PremiumThe Fly
Theriva Biologics receives CHMP scientific advice on VCN-01 Phase 3 design
4M ago
TOVX
Theriva Biologics Reschedules Special Stockholder Meeting
PremiumCompany Announcements
Theriva Biologics Reschedules Special Stockholder Meeting
5M ago
8K
TOVX
Theriva Biologics Advances Oncology Pipeline with VCN-01
PremiumCompany Announcements
Theriva Biologics Advances Oncology Pipeline with VCN-01
6M ago
TOVX
Theriva Biologics reports Q3 EPS (45c) vs ($6.81) last year
PremiumThe FlyTheriva Biologics reports Q3 EPS (45c) vs ($6.81) last year
6M ago
TOVX
Theriva Biologics files to sell 16.18M shares of common stock for holders
Premium
The Fly
Theriva Biologics files to sell 16.18M shares of common stock for holders
6M ago
TOVX
Theriva Biologics sees no material development to account for unusual trading
Premium
The Fly
Theriva Biologics sees no material development to account for unusual trading
6M ago
TOVX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >